Published in Proc Natl Acad Sci U S A on February 01, 1975
Correlation between tumor induction and the large external transformation sensitive protein on the cell surface. Proc Natl Acad Sci U S A (1976) 2.76
Diverse mitogenic agents induce the phosphorylation of two related 42,000-dalton proteins on tyrosine in quiescent chick cells. Mol Cell Biol (1984) 2.28
Immunological characterization of a major transformation-sensitive fibroblast cell surface glycoprotein. Localization, redistribution, and role in cell shape. J Cell Biol (1978) 2.05
Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J Cell Biol (1976) 1.69
Proteases induce secretion of collagenase and plasminogen activator by fibroblasts. Proc Natl Acad Sci U S A (1978) 1.40
A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun (1989) 1.35
Changes in the distribution of a major fibroblast protein, fibronectin, during mitosis and interphase. J Cell Biol (1977) 1.18
Binding and internalization of thrombin by normal and transformed chick cells. Proc Natl Acad Sci U S A (1977) 1.02
Expression of a high molecular weight cell surface glycoprotein (LETS protein) by preimplantation mouse embryos and teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1978) 0.88
Protease effects on specific growth properties of normal and transformed baby hamster kidney cells. Proc Natl Acad Sci U S A (1977) 0.80
Differential effect of thrombin on the growth of human fibroblasts. J Cell Biol (1980) 0.79
Binding of thrombin to cultured human fibroblasts: evidence for receptor modulation. J Cell Biol (1980) 0.79
Exclusion of bioactive contaminations in Streptococcus pyogenes erythrogenic toxin A preparations by recombinant expression in Escherichia coli. Infect Immun (1997) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Bacteriophage T7. Science (1972) 13.19
Alteration of cell-surface proteins by viral transformation and by proteolysis. Proc Natl Acad Sci U S A (1973) 6.98
Exposed protein on the intact human erythrocyte. Biochemistry (1971) 4.56
Effects of local cell concentrations upon the growth of chick embryo cells in tissue culture. Exp Cell Res (1968) 3.94
Proteolytic enzymes initiating cell division and escape from contact inhibition of growth. Nature (1970) 3.84
Release from density dependent growth inhibition by proteolytic enzymes. Nature (1970) 3.20
Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci U S A (1975) 3.20
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med (1973) 3.16
Changes in membrane polypeptides that occur when chick embryo fibroblasts and NRK cells are transformed with avian sarcoma viruses. Virology (1974) 3.14
A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A (1971) 2.97
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
A comparison of membrane proteins of normal and transformed cells by lactoperoxidase labeling. Proc Natl Acad Sci U S A (1974) 2.59
Isolation and properties of a thrombin-sensitive protein of human platelets. J Biol Chem (1972) 2.54
Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry (1972) 2.41
Novel human serum protein from fibroblast plasma membrane. Nature (1974) 2.35
Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem (1973) 1.72
Selective inhibition of growth of transformed cells by protease inhibitors. Proc Natl Acad Sci U S A (1972) 1.57
Proteins exposed on the surface of mammalian membranes. Biochemistry (1972) 1.51
Plasma membrane proteins of normal and Rous sarcoma virus-transformed chick-embryo fibroblasts. Nat New Biol (1973) 1.37
Thrombin substrates and the proteolytic site of thrombin action on human-platelet plasma membranes. Biochim Biophys Acta (1974) 1.15
Cleavage of actin by thrombin. Proc Natl Acad Sci U S A (1974) 1.07
Characterization of the external proteins of hamster fibroblasts. J Cell Biol (1974) 1.03
Organization of glycolipids and glycoproteins in surface membranes: dependency on cell cycle and on transformation. Biochem Biophys Res Commun (1974) 1.02
Activation of trypsinogen and plasminogen by thrombin preparations. Biochemistry (1966) 0.86
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med (1991) 9.99
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer (2006) 2.67
Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A (1985) 2.26
Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production. Proc Natl Acad Sci U S A (1983) 1.70
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol (1989) 1.67
Mitogenicity of thrombin and surface alterations on mouse splenocytes. Exp Cell Res (1976) 1.38
Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion. Proc Natl Acad Sci U S A (1985) 1.30
Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab (1990) 1.24
The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int Immunol (1992) 1.15
VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. J Rheumatol (1999) 1.09
Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer (2006) 1.08
Characterization of an alpha-bungarotoxin binding component from Drosophila melanogaster. J Neurochem (1977) 1.07
Production of human monoclonal IgG antibodies against Rhesus (D) antigen. Proc Natl Acad Sci U S A (1984) 1.07
Lipopolysaccharide and peptidoglycan share binding sites on human peripheral blood monocytes. J Infect Dis (1993) 1.02
Thrombin-sensitive surface protein of cultured chick embryo cells. Nature (1976) 0.99
Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells. J Immunol (1993) 0.97
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer (2007) 0.95
Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II. Clin Exp Immunol (1997) 0.92
Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies. Clin Exp Immunol (1996) 0.90
Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma. Gynecol Oncol (1996) 0.89
Appearance of acetylcholine receptors in cultured myoblasts prior to fusion. J Supramol Struct (1976) 0.89
Recognition of auto- and exoantigens by V4-34 gene encoded antibodies. Scand J Immunol (2000) 0.87
Operative laparoscopy in the management of ovarian cancer. Surg Laparosc Endosc (1996) 0.85
Modified posterior exenteration for ovarian cancer. Obstet Gynecol (1991) 0.84
Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies. Gynecol Oncol (1990) 0.83
Gynecologic factors in sexual dysfunction of the older woman. Clin Geriatr Med (1991) 0.83
Human CD5+ B lymphocytes (B-1 cells) decrease in peripheral blood during pregnancy. J Reprod Immunol (1995) 0.83
Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys (2000) 0.82
Influence of avidity and idiotope recognition on the modulation of surface immunoglobulin on malignant human B cells by rat monoclonal anti-idiotype antibodies. J Immunol (1986) 0.81
Anti-endotoxin human monoclonal antibody A6H4C5 (HA-1A) utilizes the VH4.21 gene. Clin Infect Dis (1995) 0.81
Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol (1993) 0.80
Effects of anti-lipid A human monoclonal antibody on lipopolysaccharide-induced toxicity to the kidney. J Urol (1989) 0.80
Susceptibility of B-cell lymphoma to human antibodies encoded by the V4-34 gene. Crit Rev Oncol Hematol (2001) 0.80
Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancer. Cancer (1992) 0.79
Somatic cell hybrid selection with a transfectable dominant marker. Somat Cell Mol Genet (1984) 0.78
Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple glandular epithelium. Hum Antibodies Hybridomas (1992) 0.78
Partial hydatidiform mole with diploid karyotype: report of three cases. Am J Obstet Gynecol (1984) 0.78
The effect of human antiendotoxin monoclonal antibodies on endotoxin-induced lung injury in the rat. Am Rev Respir Dis (1987) 0.78
Cytotoxicity of murine B lymphocytes induced by human VH4-34 (VH4.21) gene-encoded monoclonal antibodies. Clin Immunol Immunopathol (1997) 0.78
Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes. J Immunol Methods (1987) 0.76
Delivery of a normal infant following cisplatin, vinblastine, and bleomycin (PVB) chemotherapy for malignant teratoma of the ovary during pregnancy. Gynecol Oncol (1990) 0.76
FACS analysis of peritoneal lymphocytes in ovarian cancer and control patients. Immunobiology (1994) 0.76
One-step enrichment of nucleated red blood cells. A potential application in perinatal diagnosis. J Immunol Methods (1993) 0.76
Prospective randomized trial of topical alpha-interferon (alpha-interferon gels) for the treatment of vulvar intraepithelial neoplasia III. Gynecol Oncol (1990) 0.76
VH4-34 (VH4.21) gene expression in the chronic arthritides of childhood: studies of associations with anti-lipid A antibodies, HLA antigens, and clinical features. J Rheumatol (1996) 0.76
Clinical practice guidelines in the management of gynecologic malignancies. Hematol Oncol Clin North Am (1999) 0.75
Clinical applications of monoclonal antibodies in gynecologic oncology. Cancer (1987) 0.75
Second-look laparotomy in epithelial ovarian carcinoma: precise definition, sensitivity, and specificity of the operative procedure. Gynecol Oncol (1984) 0.75
The female genital tract. Pathology (Phila) (1996) 0.75
Quantitative protein changes in metastatic versus primary epithelial ovarian carcinoma. Gynecol Oncol (1991) 0.75
A critical reassessment of second-look laparotomy in epithelial ovarian carcinoma. Cancer (1986) 0.75
Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia. Am J Obstet Gynecol (1983) 0.75
Documentation of complete resolution of gestational choriocarcinoma in the oophorectomized patient. Gynecol Oncol (1993) 0.75
One step separation of human fetal lymphocytes from nucleated red blood cells. J Immunol Methods (1990) 0.75
Heavy chain variable gene usage by human B-1 lymphocytes and polyreactive autoantibodies. Hum Antibodies (1997) 0.75
Synthesis and characterization of gentiobiose heptaacetate conjugate vaccines that produce endotoxin-neutralizing antibodies. Bioconjug Chem (1991) 0.75
Epithelial ovarian carcinoma in patients with intersex disorders: the role of pituitary gonadotropins in ovarian tumorigenesis. Gynecol Oncol (1986) 0.75
The role of laparoscopy in the management of gynecologic malignancy. Semin Surg Oncol (1995) 0.75
Cardiovascular effect of intravenous lipid A in rabbits. Circ Shock (1987) 0.75
Human monoclonal antibody recognizing an antigen associated with ovarian and other adenocarcinomas. Am J Obstet Gynecol (1992) 0.75
Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer (1993) 0.75